Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nutrimar is a Norwegian marine biotechnology company specializing in the sustainable processing of Atlantic salmon by-products into high-quality ingredients. Based on the island of Frøya, the company operates a state-of-the-art production facility located in immediate proximity to SalMar's harvesting plant, ensuring maximum freshness of raw materials. Their core product portfolio includes salmon oil, salmon meal, and specialized enzymatic protein hydrolysates. These ingredients are primarily supplied to the global pet food, aquaculture, and human nutrition industries. Nutrimar utilizes advanced enzymatic hydrolysis technology to break down proteins into highly digestible peptides. The company is a central part of the Kverva investment group's portfolio, emphasizing a circular economy by utilizing 100% of the fish. Their commitment to traceability and sustainability makes them a preferred partner for high-end nutritional applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nutrimar.